Figure 5From: Proteomic analysis of human plasma in chronic rheumatic mitral stenosis reveals proteins involved in the complement and coagulation cascadeIdentification of pathways associated with Rheumatic Mitral Stenosis. Proteins marked by red circles indicate those that are found to be differentially abundant and/or common to the control and patient groups. Proteins indicated by blue circles are identified only in the patient group. A2M, α-2-macroglobulin; BF, complement factor B; C1Q, complement component 1,q subcomponent; C1S, complement component 1, s subcomponent; C3,complement component 3; C4,complement component C4; C4BP, complement component 4 binding protein; C9, complement component C9; F2,coagulation factor II or prothrombin; FG, fibrinogen; HF1,complement factor H; KNG, kininogen 1; PLG, plasminogen; PROS1,protein S α; SERPIN A1,serpin peptidase inhibitor, clade A member 1 or α-1-antitrypsin; SERPINC1,serpin peptidase inhibitor, clade C, member 1 or antithrombin III; SERPIND1,serpin peptidase inhibitor, clade D, member 1or heparin cofactor II; SERPING1,serpin peptidase inhibitor, clade G, member 1 or C1 inhibitor.Back to article page